Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001019687-04-002022
Filing Date
2004-09-13
Accepted
2004-09-13 16:17:29
Documents
2
Period of Report
2004-10-25
Effectiveness Date
2004-09-13

Document Format Files

Seq Description Document Type Size
1 peregrine_def14a-2004.htm DEF 14A 260727
2 GRAPHIC image001.gif GRAPHIC 5516
  Complete submission text file 0001019687-04-002022.txt   268087
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 000-17085 | Film No.: 041027721
SIC: 2835 In Vitro & In Vivo Diagnostic Substances